ArticleJournal of travel medicine2018
Business travel-associated illness: a GeoSentinel analysis.
Article in Journal of travel medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 60 citations in OpenAlex.
- Comprehensive Health Challenges and Management Strategies for International Business Travelers: A Scoping Review.JMA journal · 2025Review
- Article
- Evaluating Pre-travel Health Consultations for Business and Occupational Travelers: A Systematic Review.Cureus · 2024Review
- Travel-related gastrointestinal diseases: Assessment and management.Public health challenges · 2022Review
- Infectious diseases and predominant travel-related syndromes among long-term expatriates living in low-and middle- income countries: a scoping review.Tropical diseases, travel medicine and vaccines · 2022Article
- Key informant perspectives on sexual health services for travelling young adults: a qualitative study.BMC health services research · 2022Article
- [Knowledge of malaria and preventive attitudes of Tunisian travellers toward malaria endemic areas].The Pan African medical journal · 2022Article
- If I told you that there is no need for yellow fever vaccine booster would you still come to the travel clinic?: a cross-sectional study.Tropical diseases, travel medicine and vaccines · 2021Article
- What Is the Impact of Lockdowns on Dengue?Current infectious disease reports · 2021Review
- GeoSentinel: past, present and future†.Journal of travel medicine · 2020Review
- Malaria in travellers in the time of corona.Journal of travel medicine · 2020Article
- Re-starting travel in the era of COVID-19: preparing anew.Journal of travel medicine · 2020Article
- Dengue vaccine development by the year 2020: challenges and prospects.Current opinion in virology · 2020Review
- Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.The American journal of tropical medicine and hygiene · 2020Article
- Dengue vaccine development: status and future.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2020Review
- Yellow Fever in Travelers.Current infectious disease reports · 2019Review
- Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.Journal of Korean medical science · 2019Article
- A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.The American journal of tropical medicine and hygiene · 2019Article
- Insights into needs of business travelers to China from calls to a medical assistance provider.Heliyon · 2019Article
- Spatiotemporal characterisation and risk factor analysis of malaria outbreak in Cabo Verde in 2017.Tropical medicine and health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 15 institutions in 8 countries.
Funding
Abstract
Background: Analysis of a large cohort of business travelers will help clinicians focus on frequent and serious illnesses. We aimed to describe travel-related health problems in business travelers. Methods: GeoSentinel Surveillance Network consists of 64 travel and tropical medicine clinics in 29 countries; descriptive analysis was performed on ill business travelers, defined as persons traveling for work, evaluated after international travel 1 January 1997 through 31 December 2014. Results: Among 12 203 business travelers seen 1997-2014 (14 045 eligible diagnoses), the majority (97%) were adults aged 20-64 years; most (74%) reported from Western Europe or North America; two-thirds were male. Most (86%) were outpatients. Fewer than half (45%) reported a pre-travel healthcare encounter. Frequent regions of exposure were sub-Saharan Africa (37%), Southeast Asia (15%) and South Central Asia (14%). The most frequent diagnoses were malaria (9%), acute unspecified diarrhea (8%), viral syndrome (6%), acute bacterial diarrhea (5%) and chronic diarrhea (4%). Species was reported for 973 (90%) of 1079 patients with malaria, predominantly Plasmodium falciparum acquired in sub-Saharan Africa. Of 584 (54%) with malaria chemoprophylaxis information, 92% took none or incomplete courses. Thirteen deaths were reported, over half of which were due to malaria; others succumbed to pneumonia, typhoid fever, rabies, melioidosis and pyogenic abscess. Conclusions: Diarrheal illness was a major cause of morbidity. Malaria contributed substantial morbidity and mortality, particularly among business travelers to sub-Saharan Africa. Underuse or non-use of chemoprophylaxis contributed to malaria cases. Deaths in business travelers could be reduced by improving adherence to malaria chemoprophylaxis and targeted vaccination for vaccine-preventable diseases. Pre-travel advice is indicated for business travelers and is currently under-utilized and needs improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.